Next Article in Journal
Tumor-Associated Neutrophils Dampen Adaptive Immunity and Promote Cutaneous Squamous Cell Carcinoma Development
Next Article in Special Issue
Drug Vulnerabilities and Disease Prognosis Linked to the Stem Cell-Like Gene Expression Program Triggered by the RHO GTPase Activator VAV2 in Hyperplastic Keratinocytes and Head and Neck Cancer
Previous Article in Journal
Efficient Therapeutic Delivery by a Novel Cell-Penetrating Peptide Derived from Acinus
Previous Article in Special Issue
RAC1B Induces SMAD7 via USP26 to Suppress TGFβ1-Dependent Cell Migration in Mesenchymal-Subtype Carcinoma Cells
 
 
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Review

Hormones Secretion and Rho GTPases in Neuroendocrine Tumors

1
Institut des Neurosciences Cellulaires et Intégratives, Centre National de la Recherche Scientifique, Université de Strasbourg, F-67000 Strasbourg, France
2
Département de Chirurgie Viscérale, Métabolique et Cancérologique (CVMC), Unité Médico-chirurgicale de Chirurgie Métabolique, Endocrinienne et Thyroïdienne (UMET), Unité Médico-chirurgicale de Chirurgie de L’obésité (UMCO), Université de Lorraine, CHRU NANCY, Hôpital Brabois Adultes, F-54511 Vandœuvre-lès-Nancy, France
*
Author to whom correspondence should be addressed.
Cancers 2020, 12(7), 1859; https://doi.org/10.3390/cancers12071859
Submission received: 5 June 2020 / Revised: 3 July 2020 / Accepted: 6 July 2020 / Published: 10 July 2020
(This article belongs to the Special Issue Rho Family of GTPases in Cancer)

Abstract

Neuroendocrine tumors (NETs) belong to a heterogeneous group of neoplasms arising from hormone secreting cells. These tumors are often associated with a dysfunction of their secretory activity. Neuroendocrine secretion occurs through calcium-regulated exocytosis, a process that is tightly controlled by Rho GTPases family members. In this review, we compiled the numerous mutations and modification of expression levels of Rho GTPases or their regulators (Rho guanine nucleotide-exchange factors and Rho GTPase-activating proteins) that have been identified in NETs. We discussed how they might regulate neuroendocrine secretion.
Keywords: neuroendocrine tumors; Rho GTPases; hormone secretion; vesicular trafficking; mutations; expression changes neuroendocrine tumors; Rho GTPases; hormone secretion; vesicular trafficking; mutations; expression changes

Share and Cite

MDPI and ACS Style

Streit, L.; Brunaud, L.; Vitale, N.; Ory, S.; Gasman, S. Hormones Secretion and Rho GTPases in Neuroendocrine Tumors. Cancers 2020, 12, 1859. https://doi.org/10.3390/cancers12071859

AMA Style

Streit L, Brunaud L, Vitale N, Ory S, Gasman S. Hormones Secretion and Rho GTPases in Neuroendocrine Tumors. Cancers. 2020; 12(7):1859. https://doi.org/10.3390/cancers12071859

Chicago/Turabian Style

Streit, Laura, Laurent Brunaud, Nicolas Vitale, Stéphane Ory, and Stéphane Gasman. 2020. "Hormones Secretion and Rho GTPases in Neuroendocrine Tumors" Cancers 12, no. 7: 1859. https://doi.org/10.3390/cancers12071859

APA Style

Streit, L., Brunaud, L., Vitale, N., Ory, S., & Gasman, S. (2020). Hormones Secretion and Rho GTPases in Neuroendocrine Tumors. Cancers, 12(7), 1859. https://doi.org/10.3390/cancers12071859

Note that from the first issue of 2016, this journal uses article numbers instead of page numbers. See further details here.

Article Metrics

Back to TopTop